Merck & Co 30 year tipped to bring wave of copycats
![Pills of the drug Molnupiravir in a blister package. Molnupiravir was developed by Merck & Co and is an antiviral Covid-19 therapy. Selective focus](https://assets.euromoneydigital.com/dims4/default/664bae7/2147483647/strip/true/crop/6000x4000+0+0/resize/840x560!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2Fe1%2F2d%2Ffa4bb21c4b57a36d1e0e35456153%2F2gythtr.jpg)
‘Definitely more’ corporates seeking ultra-long maturities
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: